These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30728860)

  • 21. Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial.
    Anari F; O'Neill J; Choi W; Chen DYT; Haseebuddin M; Kutikov A; Dulaimi E; Alpaugh RK; Devarajan K; Greenberg RE; Bilusic M; Wong YN; Viterbo R; Hoffman-Censits JH; Lallas CD; Trabulsi EJ; Smaldone M; Geynisman DM; Zibelman M; Lin J; Kelly WK; Uzzo R; McConkey D; Plimack ER
    Eur Urol Oncol; 2018 May; 1(1):54-60. PubMed ID: 30420974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer.
    Lee FC; Harris W; Cheng HH; Shenoi J; Zhao S; Wang J; Champion T; Izard J; Gore JL; Porter M; Yu EY; Wright JL
    Adv Urol; 2013; 2013():317190. PubMed ID: 24382958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of neoadjuvant chemotherapy in invasive bladder cancer.
    Cam K; Yildirim A; Ozveri H; Turkeri L; Akdas A
    Int Urol Nephrol; 2002; 33(1):49-52. PubMed ID: 12090338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
    Culine S; Harter V; Gravis G; Fléchon A; Chevreau C; Mahammedi H; Laguerre B; Guillot A; Joly F; Abadie-Lacourtoisie S; Geoffrois L; Fiore FD; Roubaud G; Barthélémy P; Voog E; Emambux S; Serrate C; Saldana C; Nguyen-Tan-Hon T; Loriot Y; Eymard JC; Huillard O; Rolland F; Houédé N; Spano JP; Demery ME; Vieillot S; L'Haridon T; Hilgers W; Allory Y; Pfister C;
    Clin Genitourin Cancer; 2021 Dec; 19(6):554-562. PubMed ID: 34602349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
    Meeks JJ; Bellmunt J; Bochner BH; Clarke NW; Daneshmand S; Galsky MD; Hahn NM; Lerner SP; Mason M; Powles T; Sternberg CN; Sonpavde G
    Eur Urol; 2012 Sep; 62(3):523-33. PubMed ID: 22677572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.
    Anan G; Hatakeyama S; Fujita N; Iwamura H; Tanaka T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Sato M; Ohyama C
    Oncotarget; 2017 Oct; 8(49):86130-86142. PubMed ID: 29156782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
    Miron B; Hoffman-Censits JH; Anari F; O'Neill J; Geynisman DM; Zibelman MR; Kutikov A; Viterbo R; Greenberg RE; Chen D; Lallas CD; Trabulsi EJ; Alpaugh RK; Dulaimi E; Golemis EA; Uzzo R; Ross EA; Plimack ER
    Eur Urol Oncol; 2020 Aug; 3(4):544-547. PubMed ID: 32165095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
    Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
    Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant immunochemotherapy in the treatment of nonmetastatic muscle-invasive bladder cancer: a systematic review.
    Sarkis J; Vannier E; Mjaess G; Pochet C; Albisinni S; Quackels T; Roumeguère T
    Immunotherapy; 2022 Dec; 14(17):1407-1417. PubMed ID: 36448639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder.
    Rouanne M; Bajorin DF; Hannan R; Galsky MD; Williams SB; Necchi A; Sharma P; Powles T
    Eur Urol Oncol; 2020 Dec; 3(6):728-738. PubMed ID: 33177001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer.
    Benkhadra R; Nayfeh T; Patibandla SK; Peterson C; Prokop L; Alhalabi O; Murad MH; Mao SS
    Bladder Cancer; 2022; 8(1):5-17. PubMed ID: 38994516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open-label phase II to evaluate the efficacy of NEoadjuvant dose-dense MVAC In cOmbination with durvalumab and tremelimumab in muscle-invasive urothelial carcinoma: NEMIO.
    Thibault C; Elaidi R; Vano YA; Rouabah M; Braychenko E; Helali I; Audenet F; Oudard S
    Bull Cancer; 2020 Jun; 107(5S):eS8-eS15. PubMed ID: 32620213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer.
    Narayan V; Vaughn D
    Expert Opin Drug Metab Toxicol; 2015 May; 11(5):731-42. PubMed ID: 25604887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer.
    Necchi A; Raggi D; Gallina A; Ross JS; Farè E; Giannatempo P; Marandino L; Colecchia M; Lucianò R; Bianchi M; Colombo R; Salonia A; Gandaglia G; Fossati N; Bandini M; Pederzoli F; Capitanio U; Montorsi F; de Jong JJ; Dittamore R; Liu Y; Davicioni E; Boormans JL; Briganti A; Black PC; Gibb EA
    Eur Urol; 2020 Jun; 77(6):701-710. PubMed ID: 32165065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer.
    McConkey DJ; Choi W; Shen Y; Lee IL; Porten S; Matin SF; Kamat AM; Corn P; Millikan RE; Dinney C; Czerniak B; Siefker-Radtke AO
    Eur Urol; 2016 May; 69(5):855-62. PubMed ID: 26343003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
    Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
    Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].
    Pignot G; Houédé N; Roumiguié M; Audenet F; Brunelle S; Colin P; Compérat E; Larré S; Masson-Lecomte A; Neuzillet Y; Xylinas E; Méjean A; Rouprêt M;
    Prog Urol; 2018 Oct; 28(12):567-574. PubMed ID: 30205925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy (MVAC) in locally invasive bladder cancer.
    Sagaster P; Flamm J; Flamm M; Mayer A; Donner G; Oberleitner S; Havelec L; Lepsinger L; Ludwig H
    Eur J Cancer; 1996 Jul; 32A(8):1320-4. PubMed ID: 8869093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cisplatin-based neoadjuvant chemotherapy on survival in patients with bladder cancer: a meta-analysis.
    Li G; Niu HM; Wu HT; Lei BY; Wang XH; Guo XB; Feng SL
    Clin Invest Med; 2017 Apr; 40(2):E81-E94. PubMed ID: 28447581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer.
    Leibowitz-Amit R; Israel A; Gal M; Atenafu EA; Symon Z; Portnoy O; Laufer M; Dotan Z; Ramon J; Avni D; Fridman E; Berger R
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):790-796. PubMed ID: 27498850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.